How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
published in: Diabetes, Obesity and Metabolism
date of publication: 2019-01-04
main subject: type 2 diabetes
Cites articles 22
Date
Title
Article - wd:Q90405435